Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 118 articles: HTML format

Single Articles

December 2022
1. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
   ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
   Ann Surg Oncol. 2022;29:8209-8210.
   PubMed    
   
   
   
2. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
   S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
   Ann Surg Oncol. 2022;29:8198-8206.
   PubMed     Abstract available
   
   
   November 2022
3. USUZAKI T, Takahashi K, Ishikuro M, Obara T, et al
   Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer''.
   Ann Surg Oncol. 2022 Nov 16. doi: 10.1245/s10434-022-12809.
   PubMed    
   
   
   
4. SHIMADA Y
   Reply to: Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer'' by Usuzaki, Takuma et al.
   Ann Surg Oncol. 2022 Nov 14. doi: 10.1245/s10434-022-12822.
   PubMed    
   
   
   
5. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
   ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
   Ann Surg Oncol. 2022;29:7551-7552.
   PubMed    
   
   
   
6. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
   ASO Visual Abstract: Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
   Ann Surg Oncol. 2022;29:7483-7484.
   PubMed    
   
   
   
7. COURELLI AS, Sharma AK, Sicklick JK
   ASO Author Reflections: Co-Localization of Synchronous Gastrointestinal Stromal Tumors (GISTs) and Peritoneal Mesothelioma (PM): A Case Series.
   Ann Surg Oncol. 2022;29:7549-7550.
   PubMed    
   
   
   
8. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
   Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
   Ann Surg Oncol. 2022;29:7542-7548.
   PubMed     Abstract available
   
   
   
9. OLIVER AL, Takahashi-Pipkin C, Wong JH, Burch AE, et al
   Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina.
   Ann Surg Oncol. 2022;29:7485-7493.
   PubMed     Abstract available
   
   
   
10. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
    Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
    Ann Surg Oncol. 2022;29:7473-7482.
    PubMed     Abstract available
    
    
    October 2022
11. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Oct 28. pii: 10.1245/s10434-022-12717.
    PubMed    
    
    
    
12. LI D, Deng C, Fu F, Bai J, et al
    ASO Visual Abstract: Impact of Prior Cancer History on Outcomes of Resected Lung Cancer.
    Ann Surg Oncol. 2022 Oct 20. pii: 10.1245/s10434-022-12658.
    PubMed    
    
    
    
13. BONNER SN, He C, Clark M, Adams K, et al
    ASO Visual Abstract: Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
    Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12546.
    PubMed    
    
    
    
14. GOMBODORJ N, Azuma Y, Yokobori T, Erkhem-Ochir B, et al
    RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2022;29:7149-7162.
    PubMed     Abstract available
    
    
    September 2022
15. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
    ASO Visual Abstract: Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
    Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12534.
    PubMed    
    
    
    
16. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 21. pii: 10.1245/s10434-022-12565.
    PubMed     Abstract available
    
    
    
17. HERREROS-POMARES A, Jantus-Lewintre E
    ASO Author Reflections: Key Components of the Hedgehog Signaling Pathway as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12590.
    PubMed    
    
    
    
18. SHIMADA Y
    ASO Author Reflections: The Clinical Use of Radiomics with Artificial Intelligence in Patients with Early-Stage Lung Cancer.
    Ann Surg Oncol. 2022 Sep 13. pii: 10.1245/s10434-022-12518.
    PubMed    
    
    
    
19. WANG Z, Yang Z, Li S, Zhang J, et al
    ASO Visual Abstract: A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgical Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12413.
    PubMed    
    
    
    
20. TEKE ME, Saif A, Sarvestani AL, Hernandez JM, et al
    A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12488.
    PubMed    
    
    
    
21. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
    Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
    Ann Surg Oncol. 2022 Sep 7. pii: 10.1245/s10434-022-12516.
    PubMed     Abstract available
    
    
    
22. WANG Y, Chen Y, Yang Z, Qian F, et al
    Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
    Ann Surg Oncol. 2022;29:5666-5678.
    PubMed     Abstract available
    
    
    
23. WANG Y, Han B
    ASO Author Reflections: Pure and Combined Surgically Resected Large Cell Neuroendocrine Carcinoma of Lung: Could They be Evaluated as a Single Entity?
    Ann Surg Oncol. 2022;29:5679-5680.
    PubMed    
    
    
    
24. KAWAKATSU S, Shimizu Y, Natsume S, Okuno M, et al
    Prognostic Significance of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: A Single-Center Experience and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:5972-5983.
    PubMed     Abstract available
    
    
    
25. XU W, Dai W, Gao Z, Wang XS, et al
    Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery.
    Ann Surg Oncol. 2022;29:5593-5604.
    PubMed     Abstract available
    
    
    August 2022
26. BONNER SN, He C, Clark M, Adams K, et al
    Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
    Ann Surg Oncol. 2022 Aug 26. pii: 10.1245/s10434-022-12435.
    PubMed     Abstract available
    
    
    
27. YANG Z, Wang Z, Liu L
    ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2022 Aug 21. pii: 10.1245/s10434-022-12398.
    PubMed    
    
    
    
28. WANG Z, Yang Z, Li S, Zhang J, et al
    A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12363.
    PubMed     Abstract available
    
    
    
29. CHENG X, Zeng W, Liu Y, Song Z, et al
    ASO Visual Abstract: Impact of Lymph Node Dissection on Survival and Tumor Recurrence in Patients with Resected cT1-2N0 Small-Cell Lung Cancer.
    Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12283.
    PubMed    
    
    
    
30. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02.
    Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12320.
    PubMed    
    
    
    
31. KLEMEN ND, Court CM, Fernandes MC, Walch HS, et al
    Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12095.
    PubMed     Abstract available
    
    
    July 2022
32. CHENG X, Zeng W, Liu Y, Song Z, et al
    Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12215.
    PubMed     Abstract available
    
    
    
33. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
    PubMed     Abstract available
    
    
    
34. BURCH AE, Wong JH, Irish WD
    ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina.
    Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12179.
    PubMed    
    
    
    June 2022
35. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
    ASO Visual Abstract: Clinical Impact of Sarcopenia 1 Year after Surgery in Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12068.
    PubMed    
    
    
    
36. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
    Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 21. pii: 10.1245/s10434-022-11999.
    PubMed     Abstract available
    
    
    
37. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
    Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-11904.
    PubMed     Abstract available
    
    
    
38. USHITANI Y, Shimada Y
    ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer.
    Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12026.
    PubMed    
    
    
    
39. BAILEY J, Van Haren RM
    Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations.
    Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11943.
    PubMed    
    
    
    
40. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
    ASO Visual Abstract: Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11907.
    PubMed    
    
    
    
41. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
    Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jun 2. pii: 10.1245/s10434-022-11835.
    PubMed     Abstract available
    
    
    May 2022
42. DONINGTON JS
    Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.
    Ann Surg Oncol. 2022 May 27. pii: 10.1245/s10434-022-11915.
    PubMed    
    
    
    
43. IWASAKI M, Ishihara S, Inoue M
    ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 May 25. pii: 10.1245/s10434-022-11886.
    PubMed    
    
    
    
44. KUO SW, Chen PH, Lu TP, Chen KC, et al
    ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11687.
    PubMed    
    
    
    
45. KHAN TM, Verbus EA, Gandhi S, Heymach JV, et al
    Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11627.
    PubMed    
    
    
    
46. TEKE ME, Sarvestani AL, Hernandez JM, Fernando HC, et al
    A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11584.
    PubMed    
    
    
    
47. DONINGTON JS
    The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations.
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11764.
    PubMed    
    
    
    
48. DHANASOPON AP, Boffa DJ
    Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery.
    Ann Surg Oncol. 2022 May 3. pii: 10.1245/s10434-022-11797.
    PubMed    
    
    
    
49. YUN JK, Kim YH
    ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?
    Ann Surg Oncol. 2022;29:2840-2841.
    PubMed    
    
    
    April 2022
50. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11714.
    PubMed    
    
    
    
51. CUI C, Lian B, Zhang X, Wu D, et al
    An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11670.
    PubMed     Abstract available
    
    
    March 2022
52. CHEN PH, Kuo SW, Chen JS
    ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.
    Ann Surg Oncol. 2022 Mar 21. pii: 10.1245/s10434-022-11487.
    PubMed    
    
    
    
53. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11483.
    PubMed     Abstract available
    
    
    
54. KEPENEKIAN V, Peron J, You B, Bonnefoy I, et al
    Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Ann Surg Oncol. 2022;29:2104-2113.
    PubMed     Abstract available
    
    
    
55. KEPENEKIAN V, Peron J, You B, Glehen O, et al
    ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection.
    Ann Surg Oncol. 2022;29:2114-2115.
    PubMed    
    
    
    February 2022
56. WANKHEDE D, Grover S
    ASO Visual Abstract: Outcomes Following Curative Metastasectomy for Patients with Malignant Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-022-11391.
    PubMed    
    
    
    
57. WANG ZN, Jiang XB, Lu J, Guo XY, et al
    Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
    Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11365.
    PubMed     Abstract available
    
    
    
58. LIU C, Wang W, Mei J, Zhu Y, et al
    Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2022;29:1389-1391.
    PubMed     Abstract available
    
    
    January 2022
59. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    ASO Visual Abstract: Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11282.
    PubMed    
    
    
    
60. YUN JK, Yoo S, Lee GD, Choi S, et al
    Comparison of Long-Term Outcomes Between Minimally Invasive Pulmonary Resection With and Without Video-Assisted Mediastinoscopic Lymphadenectomy for Left-Sided Lung Cancer.
    Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11191.
    PubMed     Abstract available
    
    
    
61. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients With Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11024.
    PubMed     Abstract available
    
    
    
62. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
    PubMed     Abstract available
    
    
    
63. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11192.
    PubMed     Abstract available
    
    
    
64. KARUSH JM
    Segmentectomy...Because We Can or Because We Should?
    Ann Surg Oncol. 2022;29:28-29.
    PubMed    
    
    
    
65. DAI W, Mu Y, Chang S, Wu Z, et al
    ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
    Ann Surg Oncol. 2022;29:557-558.
    PubMed    
    
    
    
66. LI Z, He W, Wang C
    ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
    Ann Surg Oncol. 2022;29:570-571.
    PubMed    
    
    
    December 2021
67. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function.
    Ann Surg Oncol. 2021;28:8356-8357.
    PubMed    
    
    
    
68. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Postoperative Pulmonary Function After Complex Segmentectomy.
    Ann Surg Oncol. 2021;28:8347-8355.
    PubMed     Abstract available
    
    
    
69. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:8398-8411.
    PubMed     Abstract available
    
    
    
70. LEE G, Yoon S, Ahn B, Kim HR, et al
    ASO Visual Abstract: Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
71. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    ASO Visual Abstract: Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
72. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    ASO Visual Abstract: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
73. SHIGEFUKU S
    Reply to "Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients" by Guowei Che et al.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
74. WANG Y, Che G
    Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    November 2021
75. SUN C, Anraku M, Nakajima J
    ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11025.
    PubMed    
    
    
    
76. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    ASO Visual Abstract: Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients with Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11071.
    PubMed    
    
    
    
77. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    ASO Visual Abstract: Non-small Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection-can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11061.
    PubMed    
    
    
    
78. JOHANSON H, Okereke I
    The Importance of Clinical Decision-Making in Surgical Planning for Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11027.
    PubMed    
    
    
    
79. DAI W, Chang S, Pompili C, Qiu B, et al
    Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10946.
    PubMed     Abstract available
    
    
    
80. LEE G, Yoon S, Ahn B, Kim HR, et al
    Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:7279-7290.
    PubMed     Abstract available
    
    
    October 2021
81. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-10982.
    PubMed     Abstract available
    
    
    
82. DAI W, Chang S, Pompili C, Qiu B, et al
    ASO Visual Abstract: Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Oct 23. pii: 10.1245/s10434-021-10963.
    PubMed    
    
    
    
83. HANDA Y, Tsutani Y, Okada M
    Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10684.
    PubMed    
    
    
    
84. SHI Y, Wu S, Ma S, Lyu Y, et al
    Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10857.
    PubMed     Abstract available
    
    
    
85. ZHU Y, Xia L, Liu C, Lin F, et al
    Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2021;28:6407.
    PubMed     Abstract available
    
    
    
86. NISHINO T, Toba H, Yoshida T, Inoue S, et al
    Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
    Ann Surg Oncol. 2021;28:6398-6406.
    PubMed     Abstract available
    
    
    
87. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
    Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
    Ann Surg Oncol. 2021;28:5829-5839.
    PubMed     Abstract available
    
    
    
88. LI S, Qiao S, Li N, Zhu X, et al
    MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10688.
    PubMed     Abstract available
    
    
    
89. LEPPELMANN KS, Fintelmann FJ
    ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases.
    Ann Surg Oncol. 2021;28:5840-5841.
    PubMed    
    
    
    September 2021
90. WEI X, Yu H, Dai W, Mu Y, et al
    Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
    PubMed    
    
    
    
91. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10037.
    PubMed    
    
    
    August 2021
92. DENG HY
    Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?
    Ann Surg Oncol. 2021 Aug 21. pii: 10.1245/s10434-021-10671.
    PubMed    
    
    
    
93. WANG C, Wang S, Li Z, He W, et al
    ASO Visual Abstract: A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10542.
    PubMed    
    
    
    
94. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4542-4550.
    PubMed     Abstract available
    
    
    
95. ZHAO ZR, Long H
    ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4551-4552.
    PubMed    
    
    
    July 2021
96. WANG C, Wang S, Li Z, He W, et al
    A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
    PubMed     Abstract available
    
    
    
97. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
    PubMed     Abstract available
    
    
    
98. FU X, Wang F, Su X, Luo G, et al
    Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
    Ann Surg Oncol. 2021;28:3930-3938.
    PubMed     Abstract available
    
    
    
99. KIM IA, Hur JY, Kim HJ, Park JH, et al
    Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3983-3993.
    PubMed     Abstract available
    
    
    
100. KIM IA, Kim WS, Lee KY
     ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:3994-3995.
     PubMed    
     
     
     June 2021
101. CHIANG XH, Lin MW, Hsu HH, Chen JS, et al
     ASO Author Reflection: Comparing Wedge Resection and Segmentectomy as the Appropriate Surgical Method in cT1N0 Lung Cancer.
     Ann Surg Oncol. 2021 Jun 5. pii: 10.1245/s10434-021-10214.
     PubMed    
     
     
     
102. NAKAMURA A, Kondo N, Nakamichi T, Hashimoto M, et al
     Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
     Ann Surg Oncol. 2021;28:3057-3065.
     PubMed     Abstract available
     
     
     
103. MATSUBARA T, Okamoto T
     ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
     Ann Surg Oncol. 2021;28:3055-3056.
     PubMed    
     
     
     May 2021
104. WEI X, Yu H, Shi Q
     ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
     Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10018.
     PubMed    
     
     
     
105. LOTZE MT, Dhupar R
     ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking Bad.
     Ann Surg Oncol. 2021;28:2728-2729.
     PubMed    
     
     
     April 2021
106. MIMAE T, Saji H, Nakamura H, Okumura N, et al
     Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
     Ann Surg Oncol. 2021 Apr 26. pii: 10.1245/s10434-021-09835.
     PubMed     Abstract available
     
     
     
107. WEI X, Yu H, Dai W, Mu Y, et al
     Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
     Ann Surg Oncol. 2021 Apr 20. pii: 10.1245/s10434-021-09981.
     PubMed     Abstract available
     
     
     
108. GOOSEMAN MR, Brunelli A
     Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
     Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-10039.
     PubMed    
     
     
     
109. KANTOR T, Wakeam E
     Landmark Trials in the Surgical Management of Mesothelioma.
     Ann Surg Oncol. 2021;28:2037-2047.
     PubMed     Abstract available
     
     
     
110. CHEN D, Ding Q, Wang W, Wang X, et al
     Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:2088-2098.
     PubMed     Abstract available
     
     
     
111. KAGIMOTO A, Tsutani Y, Okada M
     ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
     Ann Surg Oncol. 2021;28:2076-2077.
     PubMed    
     
     
     
112. KAGIMOTO A, Tsutani Y, Handa Y, Mimae T, et al
     Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:2068-2075.
     PubMed     Abstract available
     
     
     February 2021
113. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
     Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
     Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
     PubMed     Abstract available
     
     
     
114. VAN VEENENDAAL LM, Bertolli E, Korse CM, Klop WMC, et al
     The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
     Ann Surg Oncol. 2021;28:1019-1028.
     PubMed     Abstract available
     
     
     January 2021
115. SHIGEFUKU S, Shimada Y
     ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:157-158.
     PubMed    
     
     
     
116. OHTSUKA T
     Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
     Ann Surg Oncol. 2021;28:14-15.
     PubMed    
     
     
     October 2020
117. DEMMY TL
     The Musician, Instrument, or Orchestra?
     Ann Surg Oncol. 2020;27:4088-4090.
     PubMed    
     
     
     
118. JUNG W, Cho S
     ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA).
     Ann Surg Oncol. 2020;27:4404.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: